An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.

Show other versions (2)

OBJECTIVE: To independently evaluate the performance of the QRISK score for predicting 10 year risk of cardiovascular disease in an independent UK cohort of patients from general practice and compare the performance with Framingham equations. DESIGN: Prospective open cohort study. SETTING: 274 pract...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Collins, G, Altman, D
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2009

Eitemau Tebyg

An independent external validation and evaluation of QRISK cardiovascular risk prediction: A prospective open cohort study
gan: Collins, G, et al.
Cyhoeddwyd: (2009)

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study
gan: Collins, G, et al.
Cyhoeddwyd: (2009)

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.
gan: Collins, G, et al.
Cyhoeddwyd: (2010)

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.
gan: Collins, G, et al.
Cyhoeddwyd: (2010)

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study
gan: Collins, G, et al.
Cyhoeddwyd: (2010)

Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.
gan: Collins, G, et al.
Cyhoeddwyd: (2012)

Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.
gan: Collins, G, et al.
Cyhoeddwyd: (2012)

QRISK validation and evaluation Authors' reply
gan: Collins, G, et al.
Cyhoeddwyd: (2009)

Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank
gan: Parsons, RE, et al.
Cyhoeddwyd: (2023)

QRISK validation and evaluation. QRISK may be less useful.
gan: Liew, S, et al.
Cyhoeddwyd: (2009)

QRISK validation and evaluation: QRISK may be less useful
gan: Su, M, et al.
Cyhoeddwyd: (2009)

QRISK2-2011 predicted cardiovascular disease in adult general practice patients
gan: Collins, G, et al.
Cyhoeddwyd: (2012)

Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
gan: Hippisley-Cox, J, et al.
Cyhoeddwyd: (2017)

Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study
gan: Shona Livingstone, MSc, et al.
Cyhoeddwyd: (2021-06-01)

UPDATED VERSION OF QRISK2 Authors' reply to Bird
gan: Collins, G, et al.
Cyhoeddwyd: (2012)

Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
gan: Manpreet Singh, et al.
Cyhoeddwyd: (2022-07-01)

Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores.
gan: Collins, G, et al.
Cyhoeddwyd: (2011)

Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores.
gan: Collins, G, et al.
Cyhoeddwyd: (2011)

Predicting the adverse risk of statin treatment: an independent and external validation of Qstatin risk scores in the UK.
gan: Collins, G, et al.
Cyhoeddwyd: (2012)

Predicting the adverse risk of statin treatment: An independent and external validation of Qstatin risk scores in the UK
gan: Collins, G, et al.
Cyhoeddwyd: (2012)

Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study
gan: Shona J. Livingstone, et al.
Cyhoeddwyd: (2022-05-01)

Identifying women with undetected ovarian cancer: independent and external validation of QCancer(®) (Ovarian) prediction model.
gan: Collins, G, et al.
Cyhoeddwyd: (2013)

Prediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk?
gan: Tjeerd-Pieter van Staa, et al.
Cyhoeddwyd: (2014-01-01)

Identifying patients with undetected renal tract cancer in primary care: an independent and external validation of QCancer® (Renal) prediction model.
gan: Collins, G, et al.
Cyhoeddwyd: (2013)

External validation of QDSCORE(®) for predicting the 10-year risk of developing Type 2 diabetes.
gan: Collins, G, et al.
Cyhoeddwyd: (2011)

External validation of the QLifetime cardiovascular risk prediction tool: population cohort study
gan: Shona Livingstone, et al.
Cyhoeddwyd: (2023-04-01)

Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of QCancer(®) (Pancreas).
gan: Collins, G, et al.
Cyhoeddwyd: (2013)

Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus
gan: Xiaodie Mu, et al.
Cyhoeddwyd: (2022-11-01)

Cardiovascular risk stratification in new-onset diabetes by qrisk2 risk score and conventional risk score within 3 months of diagnosis of diabetes
gan: Sujata Hiran, et al.
Cyhoeddwyd: (2018-01-01)

Cardiovascular disease risk communication in NHS Health Checks using QRISK®2 and JBS3 risk calculators: the RICO qualitative and quantitative study
gan: Christopher J Gidlow, et al.
Cyhoeddwyd: (2021-08-01)

Predictors for independent external validation of cardiovascular risk clinical prediction rules: Cox proportional hazards regression analyses
gan: Ban, J, et al.
Cyhoeddwyd: (2018)

Predictors for independent external validation of cardiovascular risk clinical prediction rules: Cox proportional hazards regression analyses
gan: Jong-Wook Ban, et al.
Cyhoeddwyd: (2018-02-01)

Quantitative examination of video-recorded NHS Health Checks: comparison of the use of QRISK2 versus JBS3 cardiovascular risk calculators
gan: Christopher J Gidlow, et al.
Cyhoeddwyd: (2020-09-01)

QRISK 3® and ASCVD Risk Calculator in Patients with Diabetes and Their Correlation with Coronary Artery Calcium Scores
gan: Subramanian Kannan, et al.
Cyhoeddwyd: (2024-12-01)

Clinical prediction models in epidemiological studies: lessons from the application of QRISK3 to UK Biobank Data
gan: Parsons, RE, et al.
Cyhoeddwyd: (2022)

Ten-year cardiovascular disease risk and related factors in lifetime marijuana use with comorbid methamphetamine-associated psychotic disorder: a QRISK®3 study
gan: Dilek Örüm, et al.
Cyhoeddwyd: (2024-08-01)

Assessment of QRISK3 Score in Normoglycaemic, Prediabetic and Diabetic Subjects: An Observational Study
gan: Aayushee Rao, et al.
Cyhoeddwyd: (2023-07-01)

Chronic renal disease is not chronic kidney disease: implications for use of the QRISK and Joint British Societies risk scores
gan: Stevens, S, et al.
Cyhoeddwyd: (2015)

External validation of the prediction model of intradialytic hypotension: a multicenter prospective cohort study
gan: Yuhe Xiang, et al.
Cyhoeddwyd: (2024-12-01)

Predictive role of novel echocardiographic parameter aortic velocity propagation, QRISK3 and Framingham risk score for presence and severity of CAD in Asian patients
gan: Pooja Vyas, et al.
Cyhoeddwyd: (2022-09-01)